BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37171793)

  • 1. m
    Yang X; Bai Q; Chen W; Liang J; Wang F; Gu W; Liu L; Li Q; Chen Z; Zhou A; Long J; Tian H; Wu J; Ding X; Zhou N; Li M; Yang Y; Cai J
    Adv Sci (Weinh); 2023 Jul; 10(20):e2206744. PubMed ID: 37171793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF2BP3 is an essential N
    Xu X; Cui J; Wang H; Ma L; Zhang X; Guo W; Xue X; Wang Y; Qiu S; Tian X; Miao Y; Wu M; Yu Y; Xu Y; Wang J; Qiao Y
    Mater Today Bio; 2022 Dec; 17():100503. PubMed ID: 36457846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of
    Guo W; Huai Q; Wan H; Guo L; Song P; Gao S; He J
    DNA Cell Biol; 2021 Feb; 40(2):316-331. PubMed ID: 33493403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker.
    Teng Y; Zhao X; Xi Y; Fu N
    Cancer Biol Ther; 2023 Dec; 24(1):2249173. PubMed ID: 37700507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
    Zhao W; Xie Y
    Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The essential roles of m
    Ma L; Xue X; Zhang X; Yu K; Xu X; Tian X; Miao Y; Meng F; Liu X; Guo S; Qiu S; Wang Y; Cui J; Guo W; Li Y; Xia J; Yu Y; Wang J
    J Exp Clin Cancer Res; 2022 Jan; 41(1):36. PubMed ID: 35078505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YTHDF1 Promotes Cyclin B1 Translation through m
    Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The m6A reader IGF2BP3 preserves NOTCH3 mRNA stability to sustain Notch3 signaling and promote tumor metastasis in nasopharyngeal carcinoma.
    Chen B; Huang R; Xia T; Wang C; Xiao X; Lu S; Chen X; Ouyang Y; Deng X; Miao J; Zhao C; Wang L
    Oncogene; 2023 Nov; 42(48):3564-3574. PubMed ID: 37853162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of
    Ni XF; Xie QQ; Zhao JM; Xu YJ; Ji M; Hu WW; Wu J; Wu CP
    Aging (Albany NY); 2021 Jan; 13(3):4357-4369. PubMed ID: 33495421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
    Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
    Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide investigation of the clinical significance and prospective molecular mechanism of minichromosome maintenance protein family genes in patients with Lung Adenocarcinoma.
    Liu K; Kang M; Liao X; Wang R
    PLoS One; 2019; 14(7):e0219467. PubMed ID: 31323040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZEB1-activated LINC01123 accelerates the malignancy in lung adenocarcinoma through NOTCH signaling pathway.
    Zhang M; Han Y; Zheng Y; Zhang Y; Zhao X; Gao Z; Liu X
    Cell Death Dis; 2020 Nov; 11(11):981. PubMed ID: 33191397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
    Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
    Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
    Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
    J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway.
    Chen X; Zhu X; Shen X; Liu Y; Fu W; Wang B
    Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):370-377. PubMed ID: 36972188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
    Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
    Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTBP3 mediates TGF-β-induced EMT and metastasis of lung adenocarcinoma.
    Dong C; Wu K; Gu S; Wang W; Xie S; Zhou Y
    Cell Cycle; 2022 Jul; 21(13):1406-1421. PubMed ID: 35323096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ-MMP2 (circ-0039411) induced by FOXM1 promotes the proliferation and migration of lung adenocarcinoma cells in vitro and in vivo.
    Lv X; Huang H; Feng H; Wei Z
    Cell Death Dis; 2020 Jun; 11(6):426. PubMed ID: 32513952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3-mediated m
    Wu Y; Chang N; Zhang Y; Zhang X; Xu L; Che Y; Qiao T; Wu B; Zhou Y; Jiang J; Xiong J; Zhang J; Zhang J
    J Exp Clin Cancer Res; 2021 Mar; 40(1):90. PubMed ID: 33676554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.